Inflammation and Cardiovascular Disease in RA
Inflammation and Cardiovascular Disease in RA
批准号:
7233560
负责人:
Joan Marie Bathon
金额:
$57.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2009-04-30
关键词:
AcuteAgeAnkleArthritisAtherosclerosisBiological MarkersBlood PressureCalciumCardiovascular DiseasesCardiovascular systemCell Adhesion MoleculesCessation of lifeChronicClinicalClinical ManagementCongestive Heart FailureCoronaryCoronary ArteriosclerosisCross-Sectional StudiesDeformityDepressed moodDiseaseDisease MarkerDoseEndotheliumEventExhibitsFunctional disorderGenderGeneral PopulationGenerationsHigh PrevalenceIndividualInflammationInflammatoryInterleukin-6LearningLeftLeft Ventricular DysfunctionLeft Ventricular FunctionMagnetic Resonance ImagingMasksMeasuresMedialModelingMorbidity - disease rateOutcomePainParticipantPathogenesisPatientsPhenotypePlayPopulationPopulation ControlPrevalenceProcessProspective StudiesRateRecruitment ActivityResearch PersonnelRheumatoid ArthritisRisk FactorsRoleScoreSerum MarkersSeveritiesSymptomsThickTimeVasodilationVentricularVentricular DysfunctionX-Ray Computed Tomographycardiovascular disorder riskcysteine rich proteindesignindexingmortalitynovelprogramsprospectiveresponsetreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is a major cause of morbidity and mortality in rheumatoid arthritis (RA). CV-related deaths, congestive heart failure, and acute CV events are increased 2-4 fold in RA patients compared to matched controls, but the prevalence of conventional risk factors for CVD is not increased. We hypothesize that inflammation due to RA promotes and exacerbates CVD, independent of conventional CV risk factors. This application is an ancillary proposal to the Multi-Ethnic Study of Atherosclerosis (MESA). We will compare the prevalence and progression of subclinical CVD in 200 RA patients to 1066 non-RA MESA participants from the Hopkins MESA Field Center. The degree to which inflammation contributes to increased CVD in RA patients will be examined, after adjusting for conventional CV risk factors. Our specific aims are as follows:
Specific Aim 1. In a cross-sectional analysis we will compare a measure of atherosclerosis (coronary calcium) and measures of left ventricular (LV) dysfunction (by magnetic resonance imaging) between RA patients and controls. We will determine whether differences between the groups in coronary calcium and LV dysfunction are explained by serum markers of inflammation in RA (e.g., CRP, interleukin-6, soluble adhesion molecules).
Specific Aim 2. In a prospective analysis, we will compare the changes in coronary calcium between RA patients and controls. We will determine the degree to which elevated serum markers of inflammation contribute to differences in progression of coronary calcium.
Specific Aim 3. We will assess the associations of various markers of inflammation and disease activity/severity, as well as conventional CV risk factors, with coronary calcium and LV dysfunction at baseline and over three years, among RA patients. Particularly, the potential dose-response relationships of various markers of inflammation and disease activity/severity to coronary calcium and LV dysfunction will be examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multidisciplinary Training in Molecular and Translational Rheumatology Research
-
批准号:10652991
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2021
-
负责人:Joan Marie Bathon
-
依托单位:
Multidisciplinary Training in Molecular and Translational Rheumatology Research
-
批准号:10441302
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2021
-
负责人:Joan Marie Bathon
-
依托单位:
Multidisciplinary Training in Molecular and Translational Rheumatology Research
-
批准号:10206896
-
项目类别:
-
资助金额:$9.32万
-
财政年份:2021
-
负责人:Joan Marie Bathon
-
依托单位:
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
-
批准号:9026031
-
项目类别:
-
资助金额:$96.36万
-
财政年份:2015
-
负责人:Joan Marie Bathon
-
依托单位:
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
-
批准号:9532568
-
项目类别:
-
资助金额:$159.42万
-
财政年份:2015
-
负责人:Joan Marie Bathon
-
依托单位:
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
-
批准号:9151628
-
项目类别:
-
资助金额:$269.9万
-
财政年份:2015
-
负责人:Joan Marie Bathon
-
依托单位:
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
-
批准号:9308669
-
项目类别:
-
资助金额:$264.65万
-
财政年份:2015
-
负责人:Joan Marie Bathon
-
依托单位:
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis
-
批准号:8641657
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2013
-
负责人:Joan Marie Bathon
-
依托单位:
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis
-
批准号:8435756
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2013
-
负责人:Joan Marie Bathon
-
依托单位:
ESCAPE - RA TRIAL
-
批准号:7607472
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2006
-
负责人:Joan Marie Bathon
-
依托单位:
OSTEOARTHRITIS INITIATIVE: A KNEE STUDY
-
批准号:7607468
-
项目类别:
-
资助金额:$5.89万
-
财政年份:2006
-
负责人:Joan Marie Bathon
-
依托单位:
SUPPRESSION OF THE GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR-1 (GH/IGF-1) AXI
-
批准号:7375806
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2005
-
负责人:Joan Marie Bathon
-
依托单位:
ESCAPE - RA TRIAL
-
批准号:7375830
-
项目类别:
-
资助金额:$8.68万
-
财政年份:2005
-
负责人:Joan Marie Bathon
-
依托单位:
OSTEOARTHRITIS INITIATIVE: A KNEE STUDY
-
批准号:7375823
-
项目类别:
-
资助金额:$56.51万
-
财政年份:2005
-
负责人:Joan Marie Bathon
-
依托单位:
Inflammation and Cardiovascular Disease in RA
-
批准号:8304882
-
项目类别:
-
资助金额:$58.44万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
Inflammation and Cardiovascular Disease in RA
-
批准号:6890485
-
项目类别:
-
资助金额:$61.64万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
SUPPRESSION OF THE GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR-1 (GH/IGF-1) AXIS
-
批准号:7204440
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
Inflammation and cardiovascular disease in RA
-
批准号:8585677
-
项目类别:
-
资助金额:$14.74万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis
-
批准号:10408660
-
项目类别:
-
资助金额:$67.59万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
Inflammation and Cardiovascular Disease in RA
-
批准号:8536513
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2004
-
负责人:Joan Marie Bathon
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: